INSIGHTS ON CONTRACT PHARMA MANUFACTURING
Supporting A Company In Manufacturing The RSM For Treating A Rare Tumour
A clinical-stage oncology company needed a partner to manufacture the RSM. Examine how an optimized RSM manufacturing process helped deliver safe, effective treatment on an accelerated timeline.
The Growth Of Sterile Injectables
Partnering with a manufacturer capable of delivering flexible aseptic fill-finish solutions for both small and large-scale production runs is essential for delivering products to patients safely and efficiently.
Detection And Quantification Of Process-Related Impurities
Finding a partner with the expertise and capabilities to provide solutions for detecting and quantifying process-related impurities ensures the successful development and manufacturing of safe and effective products.
High Potent Formulation Development In Oncology
Examine the vital role formulation development plays in oncology outsourcing and how sponsors can increase their chances of success with the right CDMO partner.
Pharma Research, Development, And Launches Saves Lives — And The Earth
Discover how a defined framework and way of measuring allows companies to align priorities, short- or long-term goals, and what ESG success looks like in terms of tangible measurements.
CDMO Management for Sponsors — Part 2: Handling SOPs, Multiple Partnerships, and M&A Disruptions
Day-to-day discussions between technical teams and regular brainstorming/exchange-of-information meetings are commonly understood to be vital to a partnership — ensuring the sponsor and vendor understand each other’s long- and short-term priorities — but problem-solving and mediation are equally critical communication skills.
CDMO Management for Sponsors — Part 1: Identify Partners and Nail Project Kickoff
Identifying an appropriate CDMO partner and establishing relationship structure/expectations early is an intrinsic part of leveraging the CDMO to provide the sponsor a competitive advantage. A good partner blurs the line between third-party service and extension of your company.
Streamlining Viral Vector Development And Manufacturing For Gene Therapies
Learn about MilliporeSigma's capabilities and solutions for gene therapy production as experts highlight key features of their technologies and infrastructure through a virtual tour of the GMP manufacturing facility.
Get To The GMP Clinical Stage Quickly Utilizing Scale Down Models
Explore how scale-down models can shorten timelines, accelerate process development, and advance your novel therapy to the GMP clinical stage with speed and reduced costs.
Conduits Of Industry Intel
Martin Lehr, CEO, Context Therapeutics, explains a key role of consultants – one that should be utilized more – is that of information and intelligence sources for what is happening throughout our industry.